title: Pharmacological and pharmaeconomic considerations.
authors.forename: F
authors.initials: F
authors.lastname: Blasi
authors.forename: E
authors.initials: E
authors.lastname: Concia
authors.forename: T
authors.initials: T
authors.lastname: Mazzei
authors.forename: A M
authors.initials: AM
authors.lastname: Moretti
authors.forename: G
authors.initials: G
authors.lastname: Nicoletti
authors.forename: A
authors.initials: A
authors.lastname: Novelli
authors.forename: G
authors.initials: G
authors.lastname: Tempera
mesh_terms: D000900:Anti-Bacterial Agents / Q000191:economics* / Q000627:therapeutic use*; D001419:Bacteria / Q000472:pathogenicity; D001424:Bacterial Infections / Q000188:drug therapy / Q000191:economics* / Q000382:microbiology; D029481:Bronchitis, Chronic / Q000188:drug therapy* / Q000191:economics* / Q000382:microbiology; D006801:Humans; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents